Special Issue

MicroRNAs in Cardiovascular Diseases

Submission Deadline: 31 May 2024

Guest Editor

  • Portrait of Guest Editor Rajesh  Katare

    Rajesh Katare MBBS, PhD

    Department of Physiology-HeartOtago, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand

    Interests: microRNA; gene therapy; stem cells; chronic heart failure; diabetes mellitus; cardiomyopathy; tissue engineering

    Special Issue in IMR Press journals

Special Issue Information

Dear Colleagues,

MicroRNAs (miRNAs) have significantly advanced our understanding of cardiovascular biology and pathology. MicroRNAs are small non-coding RNA molecules that play a pivotal role in post-transcriptional gene regulation. Emerging evidence has underscored their central role in cardiovascular health, as they are intricately connected to cardiac development, function, and pathological responses. Altered miRNA expression profiles have been implicated in numerous cardiovascular conditions, including diabetes, atherosclerosis, hypertension, heart failure, and myocardial infarction, among others. These small RNA entities may serve as potential biomarkers and provide new targets for therapeutic intervention, thus opening a new chapter in cardiovascular medicine. This special issue, titled “MicroRNAs in Cardiovascular Diseases”, aims to highlight the intricate interplay between miRNAs, their regulatory functions, and their implications in the pathogenesis, diagnosis, and treatment of cardiovascular diseases.

Prof. Rajesh Katare
Guest Editor

Keywords

  • cardiovascular diseases
  • microRNAs
  • non-coding RNAs
  • cardiac function
  • cardiogenesis

Share